Sign in Subscribe
United States. Securities and Exchange Commission

Xoma Corp. Files SEC Form SC 13G June 5, 2015

Strategic Insights

— 1 min read

Xoma Corp.'s recent SEC filing highlights the company's focus on developing pharmaceutical preparations. The filing, made on June 5, 2015, reveals the company's SIC code and contact information. This document submission underscores the importance of transparency in the financial industry, as it provides stakeholders with crucial information about the company's operations and financial status.

Key Takeaways:

  • The SEC filing, Form SC 13G, provides a condensed version of the Schedule 13D, allowing certain entities to report on securities acquired in the ordinary course of business without the intention of influencing control.
  • Xoma Corp. is focused on developing pharmaceutical preparations, as indicated by its SIC code 2834.
  • The company's contact information, including its address and phone number, is publicly available through the SEC filing.
  • The filing is a formal document submitted to the Securities and Exchange Commission by publicly-traded companies.
  • The report highlights the significance of transparency in the financial industry, allowing stakeholders to make informed decisions based on accurate information.
  • The SEC filing is available for public access on the agency's website.

Statistics:

  • The SEC filing was made on June 5, 2015.
  • The SIC code for Xoma Corp. is 2834.
  • The company's contact information includes an address of 2910 SEVENTH ST, BERKELEY CA 94710 and a phone number of 5106441170.
  • The SEC file number is 0000919574-15-004791.
  • The filing is a result of the company's commitment to transparency and compliance with regulatory requirements.

Sources:

  • "Xoma Corp. Files SEC Form SC 13G June 5, 2015." NewsRx LLC, 22 June 2015.

Read more